FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1078.679

Packageus.nlm.vsac
TypeValueSet
Id2.16.840.1.113762.1.4.1078.679
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.679/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.679
Version20231006
Statusactive
Date2023-10-06T01:03:19-04:00
NameSGLT2iDMASCVD
TitleSGLT2i DM ASCVD
Realmus
Authorityhl7
Purpose(Clinical Focus: Medications containing SLGT2 inhibitors that have evidence for benefit in ASCVD (that is, reduction in MACE - major adverse cardiac events) per the ADA Standards of Care in Diabetes 2023),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC:),(Inclusion Criteria: RxCUIs for medications containing one of the following: * Canagliflozin * Empagliflozin),(Exclusion Criteria: None)

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
rxnormRxNorm
rxnormRxNorm

Narrative

No narrative content found in resource

Source

Error loading source: Cannot read properties of undefined (reading 'div')